Patents by Inventor Robert S. KANIA

Robert S. KANIA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF MET KINASE
    Publication number: 20240067626
    Abstract: Provided herein are inhibitors of MET receptor tyrosine kinase, pharmaceutical compositions comprising said inhibitory compounds, and methods for using said MET kinase inhibitory compounds for the treatment of disease.
    Type: Application
    Filed: June 26, 2023
    Publication date: February 29, 2024
    Inventors: Xiaohu S. OUYANG, Toufike KANOUNI, John S. TYHONAS, Jason M. COX, Robert S. KANIA
  • INHIBITORS OF MEK KINASE
    Publication number: 20230416286
    Abstract: Provided herein are inhibitors of MEK kinase, pharmaceutical compositions comprising said inhibitory compounds, and methods for using said MEK kinase inhibitory compounds for the treatment of disease.
    Type: Application
    Filed: June 15, 2023
    Publication date: December 28, 2023
    Inventors: Toufike KANOUNI, Robert S. KANIA, Jason M. COX
  • Inhibtors of Raf kinases
    Patent number: 11814384
    Abstract: Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
    Type: Grant
    Filed: February 3, 2023
    Date of Patent: November 14, 2023
    Assignee: KINNATE BIOPHARMA INC.
    Inventors: Toufike Kanouni, Jason M. Cox, John Tyhonas, Robert S. Kania, Subhas J. Chakravorty, Young K. Chen
  • Inhibitors of MEK kinase
    Patent number: 11780862
    Abstract: Provided herein are inhibitors of MEK kinase, pharmaceutical compositions comprising said inhibitory compounds, and methods for using said MEK kinase inhibitory compounds for the treatment of disease.
    Type: Grant
    Filed: February 27, 2023
    Date of Patent: October 10, 2023
    Assignee: KINNATE BIOPHARMA INC.
    Inventors: Toufike Kanouni, Robert S. Kania, Jason M. Cox
  • INHIBITORS OF RAF KINASES
    Publication number: 20230303566
    Abstract: Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
    Type: Application
    Filed: February 3, 2023
    Publication date: September 28, 2023
    Inventors: Toufike KANOUNI, Jason M. COX, John TYHONAS, Robert S. KANIA, Subhas J. CHAKRAVORTY, Young K. CHEN
  • Inhibitors of MET kinase
    Patent number: 11753395
    Abstract: Provided herein are inhibitors of MET receptor tyrosine kinase, pharmaceutical compositions comprising said inhibitory compounds, and methods for using said MET kinase inhibitory compounds for the treatment of disease.
    Type: Grant
    Filed: December 14, 2022
    Date of Patent: September 12, 2023
    Assignee: KINNATE BIOPHARMA INC.
    Inventors: Xiaohu S. Ouyang, Toufike Kanouni, John S. Tyhonas, Jason M. Cox, Robert S. Kania
  • INHIBITORS OF MEK KINASE
    Publication number: 20230279033
    Abstract: Provided herein are inhibitors of MEK kinase, pharmaceutical compositions comprising said inhibitory compounds, and methods for using said MEK kinase inhibitory compounds for the treatment of disease.
    Type: Application
    Filed: February 27, 2023
    Publication date: September 7, 2023
    Inventors: Toufike KANOUNI, Robert S. KANIA, Jason M. COX
  • INHIBITORS OF MET KINASE
    Publication number: 20230219929
    Abstract: Provided herein are inhibitors of MET receptor tyrosine kinase, pharmaceutical compositions comprising said inhibitory compounds, and methods for using said MET kinase inhibitory compounds for the treatment of disease.
    Type: Application
    Filed: December 14, 2022
    Publication date: July 13, 2023
    Inventors: Xiaohu S. OUYANG, Toufike KANOUNI, John S. TYHONAS, Jason M. COX, Robert S. KANIA